Fibroblast Growth Factor 21 Ameliorates NaV1.5 and Kir2.1 Channel Dysregulation in Human AC16 Cardiomyocytes
Li J, Li Y, Liu Y, Yu H, Xu N, Huang D, Xue Y, Li S, Chen H, Liu J, Li Q, Zhao Y, Zhang R, Xue H, Sun Y, Li M, Li P, Liu M, Zhang Z, Li X, Du W, Wang N, Yang B. Fibroblast Growth Factor 21 Ameliorates NaV1.5 and Kir2.1 Channel Dysregulation in Human AC16 Cardiomyocytes. Frontiers In Pharmacology 2021, 12: 715466. PMID: 34630093, PMCID: PMC8493335, DOI: 10.3389/fphar.2021.715466.Peer-Reviewed Original ResearchAction potential durationVentricular arrhythmiasMyocardial infarctionMI ratsDay 1Pharmacologic effects of FGF21Saline-treated MI ratsElectrophysiological functionDay 7Cardiac sodium currentEffects of FGF21Pharmacological effectsArrhythmia modelInwardly rectifying potassiumLethal ventricular arrhythmiasAC16 cellsFGF receptorsOuabain modelRegulation of FGF21Antiarrhythmic therapyFibroblast growth factor 21Sodium currentSerum levelsPotential durationRectifying potassium
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply